Appropriate use of colistin in neonates, infants and children: Interim guidance

Appropriate use of colistin in neonates, infants and children: Interim guidance

No abstract available.

Bibliographic Details
Main Authors:	Vindana Chibabhai, Adrie Bekker, Marianne Black, Despina Demopoulos, Angela Dramowski, Nicolette M. du Plessis, Veshni Pillay-Fuentes Lorente, Trusha Nana, Helena Rabie, Gary Reubenson, Reenu Thomas
Format:	Article
Language:	English
Published:	AOSIS 2023-12-01
Series:	Southern African Journal of Infectious Diseases
Subjects:	paediatrics neonatology microbiology infectious diseases colistin polymyxin carbapenem extensively drug resistant multidrug resistant gram-negative
Online Access:	https://sajid.co.za/index.php/sajid/article/view/555

Similar Items

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
by: Ilhaam Abrahams, et al.
Published: (2023-01-01)

Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases
by: Yuanbing Wu, et al.
Published: (2024-01-01)

Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
by: Flavia Rossi, et al.

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
by: Cheng Lyu, et al.
Published: (2020-04-01)

Comparative Assessment of Disk Diffusion, E-test and Broth Dilution Methods for Determining Colistin Susceptibility in Acinetobacter Species
by: Hishmi Jeram, et al.
Published: (2021-10-01)

An Update of Mobile Colistin Resistance in Non-Fermentative Gram-Negative Bacilli
by: Piyatip Khuntayaporn, et al.
Published: (2022-06-01)

Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges
by: Ferdinando F. Andrade, et al.
Published: (2020-11-01)

Co-production of MCR-1 and NDM-1 by Escherichia coli sequence type 31 isolated from a newborn in Moscow, Russia
by: Ofeliia Sulian, et al.
Published: (2020-12-01)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020-08-01)

Colistin and carbapenem resistance among Pseudomonas and Acinetobacter clinical isolates in Menoufia University Hospitals
by: Amal Makled, et al.
Published: (2024-02-01)

Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil
by: Ana Claudia Souza Rodrigues, et al.
Published: (2019-05-01)

Molecular mechanisms of polymyxin resistance and detection of mcr genes
by: Patrik Mlynarcik, et al.
Published: (2019-02-01)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
by: Stefan Felix Ehrentraut, et al.
Published: (2020-03-01)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021-09-01)

Colistin Use in European Livestock: Veterinary Field Data on Trends and Perspectives for Further Reduction
by: Wiebke Jansen, et al.
Published: (2022-11-01)

Colistin in Light of Current Data
by: İftihar KÖKSAL, et al.
Published: (2012-12-01)

Colistin Resistance in Enterobacterales Strains – A Current View
by: ELŻBIETA M. STEFANIUK, et al.
Published: (2019-12-01)

Association of Carbapenem and Colistin Resistance in Pathogenic Gram Negative Bacteria
by: Reham Osama, et al.
Published: (2019-06-01)

Pharmacological agents for the prevention of colistin-induced nephrotoxicity
by: Mahtabalsadat Mirjalili, et al.
Published: (2022-05-01)

A study of multidrug-resistant, colistin-only-sensitive infections in intubated and mechanically ventilated patients over 2 years
by: Ipe Jacob, et al.
Published: (2020-01-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Crystal Structure of the Catalytic Domain of MCR-1 (cMCR-1) in Complex with d-Xylose
by: Zhao-Xin Liu, et al.
Published: (2018-04-01)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01)

The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges
by: Mouna Hamel, et al.
Published: (2021-02-01)

Microbiologic Cure with a Simplified Dosage of Intravenous Colistin in Adults: A Retrospective Cohort Study
by: Al-Zubairy SA
Published: (2023-06-01)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Po-Han Huang, et al.
Published: (2022-06-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Molecular epidemiology and mechanisms of carbapenem and colistin resistance in Klebsiella and other Enterobacterales from treated wastewater in Croatia
by: Ana Puljko, et al.
Published: (2024-03-01)

Performance of polymyxin B Etest in a setting of high prevalence of KPC-producing Klebsiella pneumoniae
by: Alexandre P. Zavascki, et al.
Published: (2020-09-01)

Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
by: Hakeam A. Hakeam, et al.
Published: (2021-08-01)

Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin
by: Shixing Liu, et al.
Published: (2021-07-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates
by: Yuan Wang, et al.
Published: (2024-04-01)

Occurrence of Extended Spectrum Cephalosporin-, Carbapenem- and Colistin-Resistant Gram-Negative Bacteria in Fresh Vegetables, an Increasing Human Health Concern in Algeria
by: Widad Chelaghma, et al.
Published: (2022-07-01)

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
by: Shahin najar peerayeh, et al.
Published: (2014-03-01)

Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China
by: Zhang Q, et al.
Published: (2023-02-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

A Clinico-Microbiological Study of Blood Stream Infections in a Tertiary Referral Hospital: Colistin Resistance & Challenges
by: Samandeep Kaur, et al.
Published: (2023-03-01)

Pairing Colicins B and E5 with Bdellovibrio bacteriovorus To Eradicate Carbapenem- and Colistin-Resistant Strains of Escherichia coli
by: Sumudu Upatissa, et al.
Published: (2023-06-01)

First reported genome of an mcr-9-mediated colistin-resistant Salmonella Typhimurium isolate from Brazilian livestock
by: Elma L. Leite, et al.
Published: (2020-12-01)